In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.

I believe we are about to do it again with this new AI project called Stargate

James Treace Biography and Net Worth

Director of Treace Medical Concepts

James T. Treace has served as the chairman of our board of directors since June 2014. Mr. Treace has served as the Founder and President of J&A Group, LLC, a privately funded medical device investment and consulting company, since October 2000. Before that, from November 1999 to October 2000, Mr. Treace served as President of Medtronic Xomed, a subsidiary of Medtronic plc (NYSE: MDT). From April 1996 to November 1999, Mr. Treace served as Chief Executive Officer, President and Chairman of the board of directors of Xomed Surgical Products, Inc. (NASDAQ: XOMD), until it was acquired by Medtronic plc. From July 1993 to April 1996, Mr. Treace co-founded and served as the Chief Executive Officer and Chairman of the Board at TreBay Medical Corp., an orthopaedic and microsurgical device company. From September 1981 to July 1990, he served as President and Chief Executive Officer of Concept, Inc. (NASDAQ: CCPT), now known as Conmed Linvatec (NYSE: CNMD) and from June 1966 to September 1981 as Executive Vice President of Richards Medical, now known as Smith & Nephew (NYSE: SNN). Mr. Treace previously served as Chairman of the Boards of Kyphon, Inc. (NASDAQ: KYPH), now part of Medtronic plc, Wright Medical, acquired by Stryker Corporation (NYSE: SYK) in November 2020, American Medical Systems, Inc. (NASDAQ: AMMD), now part of Endo Pharmaceuticals (NASDAQ: ENDP), and Keystone Dental, Inc., a privately-held dental implant company.

What is James T. Treace's net worth?: The estimated net worth of James T. Treace is at least $9.31 million as of August 15th, 2024. Mr. Treace owns 1,223,441 shares of Treace Medical Concepts stock worth more than $9,310,386 as of November 16th. This net worth approximation does not reflect any other investments that Mr. Treace may own. Learn More about James T. Treace's net worth.
How do I contact James T. Treace?: The corporate mailing address for Mr. Treace and other Treace Medical Concepts executives is 203 FORT WADE RD. SUITE 150, PONTE VEDRA FL, 32081. Treace Medical Concepts can also be reached via phone at 904-373-5940 and via email at [email protected]. Learn More on James T. Treace's contact information.
Has James T. Treace been buying or selling shares of Treace Medical Concepts?: James T. Treace has not been actively trading shares of Treace Medical Concepts over the course of the past ninety days. Most recently, on Thursday, August 15th, James T. Treace bought 84,000 shares of Treace Medical Concepts stock. The stock was acquired at an average cost of $5.96 per share, with a total value of $500,640.00. Following the completion of the transaction, the director now directly owns 1,223,441 shares of the company's stock, valued at $7,291,708.36. Learn More on James T. Treace's trading history.
Who are Treace Medical Concepts' active insiders?: Treace Medical Concepts' insider roster includes Sean Scanlan (SVP), Thomas Timbie (Director), James Treace (Director), John Treace (CEO), and John Treace (Director). Learn More on Treace Medical Concepts' active insiders.
Are insiders buying or selling shares of Treace Medical Concepts?: During the last twelve months, Treace Medical Concepts insiders bought shares 12 times. They purchased a total of 812,902 shares worth more than $4,206,561.76. The most recent insider tranaction occured on September, 16th when CEO John T Treace bought 50,000 shares worth more than $265,500.00. Insiders at Treace Medical Concepts own 24.4% of the company. Learn More about insider trades at Treace Medical Concepts.
Information on this page was last updated on 9/16/2024.

James T. Treace Insider Trading History at Treace Medical Concepts

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/15/2024	Buy	84,000	$5.96	$500,640.00	1,223,441
5/31/2024	Buy	25,000	$6.05	$151,250.00	1,139,441
5/28/2024	Buy	50,000	$5.07	$253,500.00	1,089,441
5/1/2023	Sell	10,000	$25.24	$252,400.00	861,441
4/28/2023	Sell	40,000	$25.01	$1,000,400.00	871,441
2/28/2023	Sell	37,316	$21.54	$803,786.64	974,125
1/30/2023	Sell	38,071	$23.20	$883,247.20	1,023,370
12/12/2022	Sell	25,000	$24.18	$604,500.00	1,061,441
10/20/2022	Sell	8,742	$23.02	$201,240.84	1,086,441
8/18/2022	Sell	34,046	$19.09	$649,938.14	1,186,441
7/18/2022	Sell	13,961	$16.09	$224,632.49	1,256,680
7/15/2022	Sell	8,456	$16.18	$136,818.08	1,270,641
7/13/2022	Sell	4,544	$16.13	$73,294.72	1,281,897
6/16/2022	Sell	20,809	$13.58	$282,586.22	1,315,632
5/25/2022	Sell	30,313	$15.35	$465,304.55	1,356,128
3/10/2022	Sell	2	$19.20	$38.40
1/18/2022	Sell	42,937	$19.46	$835,554.02
12/27/2021	Sell	6,437	$17.46	$112,390.02
12/22/2021	Sell	23,390	$16.28	$380,789.20
12/20/2021	Sell	16,119	$15.70	$253,068.30
12/15/2021	Sell	75,000	$16.06	$1,204,500.00
11/24/2021	Sell	17,000	$17.83	$303,110.00
11/22/2021	Sell	16,000	$18.52	$296,320.00
11/17/2021	Sell	25,000	$20.33	$508,250.00
11/15/2021	Sell	25,000	$20.63	$515,750.00

James T. Treace Buying and Selling Activity at Treace Medical Concepts

Treace Medical Concepts Company Overview

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Today's Range

Now: $7.61

$7.61

$7.88

50 Day Range

MA: $5.67

$4.66

$8.29

2 Week Range

Now: $7.61

$3.92

$15.98

Volume

440,495 shs

Average Volume

826,145 shs

Market Capitalization

$474.08 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.24

Bill Gates’s Next Big AI Bet: Stargate

From Brownstone Research | Ad